← Leaderboards
John Laurence Kulp III
Bioleap, Llc
$4,960,085
Attributed
$4,960,085
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,960,085 · 4
By mechanism
R44$4,283,670 · 2
R43$676,415 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Algorithms”
- David Heimbrook · Leidos Biomedical Research, Inc.$112,814,417
- Randall J Bateman · Washington University$102,126,188
- Sharon L. Walsh · University Of Kentucky$81,731,115
- Eric S Lander · Whitehead Institute For Biomedical Res$71,530,862
- David H Walker · University Of Texas Medical Br Galveston$61,066,312
- Leonard Freedman · Leidos Biomedical Research, Inc.$46,756,756
Research focus
AlgorithmsMapsDesignDrug DiscoveryProteinsAffinityGrantPharmaceutical PreparationsBindingProtein FragmentWaterRunningSimulationInnovationWeb ServicesClinical TrialsDrug DesignChemistryInternetModificationProgramsPrototypeBinding SitesFree Energy
Grant awards (8)
An Open Web Service For Fragment-based Design of Small Molecule Inhibitors$1,050,000
R44 · FY2025 · GM · contact PI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads$500,765
R44 · FY2024 · GM · contact PI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads$966,453
R44 · FY2023 · GM · contact PI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads$1,016,453
R44 · FY2022 · GM · contact PI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads$234,737
R43 · FY2020 · GM · contact PI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads$225,000
R43 · FY2020 · GM · contact PI
An Open Web Service For Fragment-based Design of Small Molecule Inhibitors$749,999
R44 · FY2019 · GM · contact PI
PCSK9-LDLR inhibitors from fragment-based design$216,678
R43 · FY2013 · HL · contact PI